X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4453) 4453
Publication (211) 211
Newsletter (51) 51
Book Review (45) 45
Book / eBook (20) 20
Magazine Article (16) 16
Book Chapter (7) 7
Conference Proceeding (5) 5
Newspaper Article (4) 4
Dissertation (2) 2
Reference (2) 2
Trade Publication Article (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (2756) 2756
male (2626) 2626
female (2043) 2043
urination - drug effects (1805) 1805
animals (1773) 1773
middle aged (1298) 1298
rats (1099) 1099
aged (1093) 1093
index medicus (1014) 1014
adult (949) 949
urology & nephrology (887) 887
urination (695) 695
urinary bladder - drug effects (659) 659
urination disorders - drug therapy (654) 654
urination - physiology (541) 541
treatment outcome (514) 514
urination disorders - etiology (506) 506
bladder (450) 450
rats, sprague-dawley (418) 418
time factors (408) 408
dose-response relationship, drug (382) 382
pharmacology & pharmacy (353) 353
urinary bladder - physiology (342) 342
aged, 80 and over (341) 341
urinary bladder - physiopathology (325) 325
double-blind method (318) 318
urination disorders (316) 316
prostatic hyperplasia - drug therapy (306) 306
muscle contraction - drug effects (290) 290
urodynamics (283) 283
urodynamics - drug effects (275) 275
blood pressure - drug effects (274) 274
urinary bladder - innervation (270) 270
kidney - drug effects (269) 269
quality of life (268) 268
urination disorders - physiopathology (259) 259
prostatic hyperplasia - complications (255) 255
overactive bladder (252) 252
adolescent (244) 244
urology (244) 244
care and treatment (239) 239
dogs (223) 223
rats, wistar (223) 223
prospective studies (218) 218
physiology (215) 215
urine (214) 214
urination disorders - chemically induced (213) 213
pressure (203) 203
urinary incontinence (199) 199
urinary bladder (198) 198
muscle, smooth - drug effects (194) 194
benign prostatic hyperplasia (191) 191
research (191) 191
mice (189) 189
reflex - drug effects (189) 189
sodium - urine (180) 180
neurosciences (179) 179
adrenergic alpha-antagonists - therapeutic use (178) 178
risk factors (176) 176
child (174) 174
urinary bladder, overactive - drug therapy (173) 173
disease models, animal (170) 170
efficacy (169) 169
micturition (163) 163
health aspects (160) 160
urinary incontinence - drug therapy (158) 158
rat (156) 156
diuresis - drug effects (155) 155
prostate (155) 155
follow-up studies (153) 153
administration, oral (151) 151
analysis (148) 148
urinary-bladder (146) 146
drug therapy (143) 143
men (137) 137
prostatic hyperplasia - physiopathology (135) 135
medicine & public health (131) 131
osmolar concentration (131) 131
women (131) 131
clinical trials as topic (130) 130
medicine, general & internal (129) 129
rats, inbred strains (129) 129
research article (129) 129
urinary bladder, overactive - physiopathology (129) 129
drug administration schedule (128) 128
cats (125) 125
heart rate - drug effects (124) 124
urethra - drug effects (124) 124
surgery (123) 123
incontinence (122) 122
potassium - urine (122) 122
surveys and questionnaires (122) 122
in vitro techniques (120) 120
drug therapy, combination (117) 117
management (117) 117
urination disorders - therapy (116) 116
diagnosis (114) 114
therapy (114) 114
muscarinic antagonists - therapeutic use (113) 113
medicine (110) 110
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3729) 3729
French (379) 379
Japanese (174) 174
German (85) 85
Russian (72) 72
Chinese (28) 28
Spanish (24) 24
Italian (20) 20
Danish (9) 9
Dutch (6) 6
Polish (6) 6
Bulgarian (5) 5
Hungarian (3) 3
Norwegian (3) 3
Swedish (3) 3
Czech (2) 2
Portuguese (2) 2
Romanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Nature Neuroscience, ISSN 1097-6256, 09/2002, Volume 5, Issue 9, pp. 856 - 860
In the urinary bladder, the capsaicin-gated ion channel TRPV1 is expressed both within afferent nerve terminals and within the epithelial cells that line the... 
CELLS | PAIN | RAT | CHANNEL | REFLEX | RESINIFERATOXIN | INTRAVESICAL CAPSAICIN | RELEASE | ATP | NEUROSCIENCES | Immunohistochemistry | Reflex - genetics | Spinal Cord - metabolism | Capsaicin - pharmacology | Muscle Contraction - genetics | Receptors, Drug - genetics | Reflex - drug effects | Urination - genetics | Male | Urinary Bladder - innervation | Urothelium - pathology | Muscle, Smooth - drug effects | Adenosine Triphosphate - metabolism | Urination - drug effects | Receptors, Drug - deficiency | Spinal Cord - cytology | Urothelium - ultrastructure | Mechanoreceptors - metabolism | Urothelium - innervation | Neurons, Afferent - drug effects | Physical Stimulation | Muscle, Smooth - innervation | Cells, Cultured | Proto-Oncogene Proteins c-fos - metabolism | Acetic Acid - pharmacology | Microscopy, Electron | Mice, Knockout | Animals | Receptors, Drug - drug effects | Visceral Afferents - metabolism | Mechanoreceptors - drug effects | Muscle Contraction - drug effects | Muscle, Smooth - physiopathology | Urinary Bladder - physiopathology | Signal Transduction - physiology | Urinary Bladder - drug effects | Mice | Spinal Cord - physiopathology | Visceral Afferents - drug effects | Neurons, Afferent - metabolism | Nitric Oxide - metabolism | Bladder | Physiological aspects | Genetic aspects | Ion channels | Research | Neurons
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 2, pp. 249 - 256
Abstract Background Overactive bladder (OAB) syndrome with urinary incontinence (UI) is prevalent in the population and impairs health-related quality of life... 
Urology | Urinary incontinence | OnabotulinumtoxinA | Overactive bladder | Botulinum toxin | POPULATION | EFFICACY | TRACT SYMPTOMS | BOTULINUM-TOXIN | DOSE-RANGING TRIAL | WOMEN | IMPACT | UROLOGY & NEPHROLOGY | QUESTIONNAIRE | ANTICHOLINERGIC THERAPY | United States | Humans | Middle Aged | Urodynamics - drug effects | Male | Neuromuscular Agents - therapeutic use | Botulinum Toxins, Type A - administration & dosage | Urinary Bladder - innervation | Botulinum Toxins, Type A - therapeutic use | Urinary Bladder, Overactive - drug therapy | Urinary Bladder, Overactive - psychology | Time Factors | Urinary Bladder, Overactive - physiopathology | Urination - drug effects | Neuromuscular Agents - administration & dosage | Adult | Female | Surveys and Questionnaires | Urinary Incontinence, Urge - drug therapy | Urinary Incontinence, Urge - physiopathology | Cholinergic Antagonists - therapeutic use | Botulinum Toxins, Type A - adverse effects | Urinary Bladder, Overactive - diagnosis | Double-Blind Method | Europe | Treatment Outcome | Urinary Incontinence, Urge - psychology | Injections, Intramuscular | Urinary Incontinence, Urge - diagnosis | Neuromuscular Agents - adverse effects | Quality of Life | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Clinical trials | Incontinence | Care and treatment
Journal Article
International Journal of Molecular Sciences, ISSN 1661-6596, 01/2017, Volume 18, Issue 1, pp. 117 - 117
Journal Article
European Urology, ISSN 0302-2838, 2013, Volume 64, Issue 3, pp. 398 - 407
Abstract Background Storage symptoms are often undertreated in men with lower urinary tract symptoms (LUTS). Objective To evaluate the combination of an... 
Urology | Storage symptoms | Overactive bladder | Voiding symptoms | Solifenacin | Tamsulosin OCAS | Lower urinary tract symptoms | OCAS | Tamsulosin | URGENCY | RELIABILITY | TRIAL | PERCEPTION | UK | UROLOGY & NEPHROLOGY | BLADDER OUTLET OBSTRUCTION | Humans | Middle Aged | Muscarinic Antagonists - adverse effects | Solifenacin Succinate | Urination Disorders - physiopathology | Urodynamics - drug effects | Male | Quinuclidines - administration & dosage | Adrenergic alpha-1 Receptor Antagonists - administration & dosage | Dose-Response Relationship, Drug | Drug Dosage Calculations | Urological Agents - adverse effects | Lower Urinary Tract Symptoms - drug therapy | Time Factors | Urination - drug effects | Adrenergic alpha-1 Receptor Antagonists - adverse effects | Urological Agents - administration & dosage | Drug Therapy, Combination | Quinuclidines - adverse effects | Urination Disorders - diagnosis | Double-Blind Method | Europe | Urination Disorders - drug therapy | Lower Urinary Tract Symptoms - physiopathology | Treatment Outcome | Tetrahydroisoquinolines - administration & dosage | Tetrahydroisoquinolines - adverse effects | Muscarinic Antagonists - administration & dosage | Lower Urinary Tract Symptoms - diagnosis | Quality of Life | Sulfonamides - adverse effects | Urinary Bladder - physiopathology | Urinary Bladder - drug effects | Aged | Sulfonamides - administration & dosage | Tamsulosin hydrochloride
Journal Article
Journal Article
Journal Article
Journal Article
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, ISSN 1931-857X, 08/2017, Volume 313, Issue 2, pp. F378 - F387
Journal Article
European Heart Journal, ISSN 0195-668X, 2006, Volume 27, Issue 23, pp. 2823 - 2832
Journal Article
Kidney International, ISSN 0085-2538, 06/2013, Volume 83, Issue 6, pp. 1076 - 1086
Journal Article